Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation (Q42491806)

1 November 2017

Rosiglitazone controls fatty acid cycling in human adipose tissue by means of glyceroneogenesis and glycerol phosphorylation (English)

1 reference

1 November 2017

0 references

0 references

1 reference

5

Charles Chapron

1 reference

1 November 2017

Stéphanie N Leroyer

1

1 reference

1 November 2017

Joan Tordjman

2

1 reference

1 November 2017

Geneviève Chauvet

3

1 reference

1 November 2017

Joëlle Quette

4

1 reference

1 November 2017

Claude Forest

6

1 reference

1 November 2017

Bénédicte Antoine

7

1 reference

1 November 2017

language of work or name

English

0 references

publication date

8 March 2006

1 reference

Journal of Biological Chemistry

1 November 2017

1 reference

1 November 2017

281

1 reference

1 November 2017

13141-13149

1 reference

1 November 2017

19

1 reference

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

1 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Peroxisome proliferator-activated receptor γ in diabetes and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

A futile metabolic cycle activated in adipocytes by antidiabetic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Glyceroneogenesis comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Glyceroneogenesis and the triglyceride/fatty acid cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Expression of phosphoenolpyruvate carboxykinase gene in human adipose tissue: induction by rosiglitazone and genetic analyses of the adipocyte-specific region of the promoter in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

The effect of pioglitazone on peroxisome proliferator-activated receptor-gamma target genes related to lipid storage in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Limitations of commonly used spectrophotometric assay methods for phosphoenolypyruvate carboxykinase activity in crude extracts of muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

A radiochemical enzymatic activity assay for glycerol kinase and hexokinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Substrate cycling between triglyceride and fatty acid in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

PPARalpha governs glycerol metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

A "futile cycle" induced by thiazolidinediones in human adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride content in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M512943200

21 January 2018

Identifiers

DOI

10.1074/JBC.M512943200

1 reference

1 November 2017

1 reference